Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

LON/0RQE stock hub

LON/0RQE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0RQEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

923.4M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0RQE

In the news

Latest news · LON/0RQE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROEn/a

P25 -54.2P50 2.1P75 13.7

ROIC-234.2

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0RQE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

167

Groups with data

Currency

CHF

Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	UK
Employees	487
Employees Change	-163%
Employees Change Percent	-25.08
Enterprise value	CHF 2B
Exchange	London Stock Exchange
Financial currency	CHF
First seen	2026-05-10
Industry	Biotechnology
Isin	CH0363463438
Last refreshed	2026-05-10
Market cap	CHF 923.4M
Price	CHF 3.75
Price currency	CHF
Rev Per Employee	453,264.99x
Sector	Healthcare
Sic	2836
Symbol	lon/0RQE
Website	https://www.idorsia.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-11.33%
EV Earnings	-19.45x
EV/FCF	-14.14x
EV/Sales	9.78x
FCF yield	-15.6%
P/B ratio	-0.87x
P/S ratio	4.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-52.81%
EBITDA Margin	-44.9%
Gross margin	44.18%
Gross Profit	CHF 91.3M
Gross Profit Growth Q	51.23%
Net Income	CHF -104.7M
Net Income Growth Quarters	2%
Pretax Margin	-47.86%
Profit Margin	-50.64%
Profit Per Employee	CHF -229,517
ROA	-14.98
Roa5y	-34.68
ROCE	-38.19
ROIC	-234.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	164.64%
Cagr3y	-23.92%
Cagr5y	-30.41%
EPS Growth Quarters	2
Revenue Growth	96.06x
Revenue Growth Q	-19.91x
Revenue Growth Quarters	6x
Revenue Growth3 Y	31.46x
Revenue Growth5 Y	25.18x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 0.45
Assets	CHF 436.5M
Cash	CHF 83M
Current Assets	CHF 211.3M
Current Liabilities	CHF 151.9M
Debt	CHF 1.2B
Debt FCF	CHF -8.24
Equity	CHF -1.1B
Interest Coverage	-8.38
Liabilities	CHF 1.5B
Long Term Assets	CHF 225.2M
Long Term Liabilities	CHF 1.4B
Net Cash	CHF -1.1B
Net Cash By Market Cap	CHF -120
Tangible Book Value	CHF -1.1B
Tangible Book Value Per Share	CHF -4.36
WACC	6.36

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.39
Inventory Turnover	1.7
Net Working Capital	CHF -16.9M
Quick ratio	0.81
Working Capital	CHF 59M
Working Capital Turnover	CHF -3.31

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-17.68%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	164.46%
200-day SMA	3.52
3Y total return	-55.97%
50-day SMA	3.57
50-day SMA vs 200-day SMA	50over200
5Y total return	-83.68%
All Time High	33.84
All Time High Change	-88.92%
All Time High Date	2020-01-24
All Time Low	0.63
All Time Low Change	493.06%
All Time Low Date	2024-12-20
ATR	0.23
Beta	1.67
Ch YTD	-13.37
High	4.07
High52	4.83
High52 Date	2025-10-08
High52ch	-22.34%
Low	3.75
Low52	1.27
Low52 Date	2025-05-09
Low52ch	196.3%
Ma50ch	5.01%
Price vs 200-day SMA	6.48%
RSI	58.03
RSI Monthly	50.44
RSI Weekly	57.45
Sharpe ratio	1.58x
Sortino ratio	2.73
Total Return	-17.68%
Tr YTD	-13.36
Tr1m	10.13%
Tr1w	-1.34%
Tr3m	4.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF -109.1M
Operating margin	-52.81

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	154,996,934%
Net Borrowing	59,792,878.2
Shares Insiders	24.42%
Shares Institutions	12.3%
Shares Qo Q	13.79%
Shares Yo Y	17.68%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF -149.4M
Average Volume	335,985.25x
Bv Per Share	-4.25
CAPEX	CHF -441,330
Ch1m	10.13
Ch1w	-1.34
Ch1y	164.5
Ch3m	4.2
Ch3y	-55.97
Ch5y	-83.68
Ch6m	19.08
Change	2.27%
Change From Open	0.46
Close	3.67
Days Gap	1.8
Depreciation Amortization	16,470,561.7
Dollar Volume	1,866,277.2
Earnings Date	2026-04-28
EBIT	CHF -109.1M
EBITDA	CHF -92.8M
EPS	CHF -0.49
F Score	3
FCF	CHF -144M
FCF EV Yield	-7.07x
Financing CF	123,812,407
Fiscal Year End	December
Founded	2,017
Income Tax	CHF 5.7M
Investing CF	3,899,825
Is Primary Listing	0
Last Earnings Date	2026-04-28
Last Report Date	2025-12-31
Ma150	3.67
Ma150ch	2.1%
Ma20	3.72
Ma20ch	0.78%
Net CF	-16,708,716
Next Earnings Date	2026-07-30
Open	3.73
Position In Range	0.36
Ppne	180,191,494.5
Price Date	2026-05-07
Relative Volume	1.52x
Revenue	206,688,835x
SBC By Revenue	2.58x
Share Based Comp	5,339,068
Tax By Revenue	2.78x
Tr6m	19.08%
Volume	497,524
Z Score	-10.58

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0RQE pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0RQE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0RQE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.3%

Share of float held by funds and institutions

Insider ownership

+24.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+17.7%

Negative means the company is buying back shares.

Technical

LON/0RQE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.0

Neutral momentum band

Price vs 200-day MA

+6.5%

50/200-day relationship not available

Beta (5Y)

1.67

More volatile than the market

Sharpe ratio

1.58

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0RQE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0RQE stock rating?

lon/0RQE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0RQE analysis?

The full report lives at /stocks/lon/0RQE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0RQE?

The latest report frames lon/0RQE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0RQE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.